Increased burden of enlarged perivascular spaces in patients with patent foramen ovale
- PMID: 39714481
- DOI: 10.1007/s00234-024-03532-7
Increased burden of enlarged perivascular spaces in patients with patent foramen ovale
Abstract
Introduction: Patent foramen ovale (PFO) patients may experience states of hypoxia and hypoperfusion, which may increase the burden of enlarged perivascular spaces (EPVS). However, to our knowledge, no data are available regarding EPVS in PFO patients. This study sought to investigate if patients with PFO exhibit a heightened burden of EPVS and to identify the mediating factors between PFO and EPVS.
Methods: A total of 108 consecutive PFO patients (PFO group) and 110 healthy controls (HC group) from January 2022 to February 2024 were enrolled. The differences in centrum semiovale EPVS (CSO-EPVS) and basal ganglia EPVS (BG-EPVS) scores between PFO and HC groups were compared. The correlations among PFO diameters, laboratory indexes, and EPVS burdens were analyzed. The relationships among them were obtained using mediation analysis.
Results: Mean age of PFO and HC group was 47.68 ± 14.47 and 48.14 ± 12.84 years. The CSO-EPVS and BG-EPVS scores were higher in PFO group than HC group (P < 0.001). The CSO-EPVS and BG-EPVS scores for PFO group were concentrated in the ranges 1-3 and 1-2 points, while for HC group were concentrated in the range 0-1 points. A positive correlation among PFO diameters and CSO-EPVS score (r = 0.62, P < 0.001), BG-EPVS score (r = 0.63, P < 0.001), and homocysteine (HCY)(r = 0.21, P = 0.03) was observed. Mediation analysis indicated that higher HCY significantly mediated the relationship between PFO diameter and BG-EPVS burden in PFO patients (P < 0.05).
Conclusion: These findings revealed the presence of glymphatic dysfunction in patients with PFO. HCY may mediate the impact of PFO diameter on glymphatic function.
Keywords: Cerebral small vessel disease; Enlarged perivascular spaces; Homocysteine; Patent foramen ovale.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Ethical approval: This retrospective study was approved by the Institutional Review Board of Zibo Central Hospital(No. 2024103). The informed consent of participants was waived due to the retrospective design of the study. All experiments were performed in accordance with the Declaration of Helsinki and all relevant guidelines and regulations. Conflict of interest: We declare that we have no conflict of interest.
Similar articles
-
The relationship between blood-brain barrier permeability and enlarged perivascular spaces: a cross-sectional study.Clin Interv Aging. 2019 May 10;14:871-878. doi: 10.2147/CIA.S204269. eCollection 2019. Clin Interv Aging. 2019. PMID: 31190773 Free PMC article.
-
Enlarged Perivascular Spaces Are Independently Associated with High Pulse Wave Velocity: A Cross-Sectional Study.J Alzheimers Dis. 2024;101(2):627-636. doi: 10.3233/JAD-240589. J Alzheimers Dis. 2024. PMID: 39213072 Free PMC article.
-
Factors associated with the location of perivascular space enlargement in middle-aged individuals undergoing brain screening in Japan.Clin Neurol Neurosurg. 2022 Dec;223:107497. doi: 10.1016/j.clineuro.2022.107497. Epub 2022 Nov 2. Clin Neurol Neurosurg. 2022. PMID: 36356441 Review.
-
Comparison of Enlarged Perivascular Spaces in Early-Onset and Late-Onset Alzheimer Disease-related Cognitive Impairment: A Single Clinic-based Study in South Korea.Alzheimer Dis Assoc Disord. 2024 Apr-Jun 01;38(2):201-204. doi: 10.1097/WAD.0000000000000614. Epub 2024 Apr 2. Alzheimer Dis Assoc Disord. 2024. PMID: 38563235 Free PMC article.
-
Enlarged perivascular spaces in multiple sclerosis on magnetic resonance imaging: a systematic review and meta-analysis.J Neurol. 2020 Nov;267(11):3199-3212. doi: 10.1007/s00415-020-09971-5. Epub 2020 Jun 13. J Neurol. 2020. PMID: 32535680 Free PMC article.
References
-
- Kishve P, Motwani R (2021) Morphometric study of fossa ovale in human cadaveric hearts: embryological and clinical relevance. ANAT CELL BIOL 54:42–50. https://doi.org/10.5115/acb.20.286 - DOI - PubMed - PMC
-
- Calvert PA, Rana BS, Kydd AC et al (2011) Patent foramen ovale: anatomy, outcomes, and closure. NAT REV CARDIOL 8:148–160. https://doi.org/10.1038/nrcardio.2010.224 - DOI - PubMed
-
- Shi F, Sha L, Li H et al (2023) Recent progress in patent foramen ovale and related neurological diseases: a narrative review. Front Neurol 14:1129062. https://doi.org/10.3389/fneur.2023.1129062 - DOI - PubMed - PMC
-
- Lovering AT, Kelly TS, DiMarco KG et al (2022) Implications of a patent foramen ovale for environmental physiology and pathophysiology: do we know the ‘hole’ story? J PHYSIOL-LONDON 600:1541–1553. https://doi.org/10.1113/JP281108 - DOI - PubMed
-
- Yang Z, Huang C, Wen X et al (2021) Circular RNA circ-FoxO3 attenuates blood-brain barrier damage by inducing autophagy during ischemia/reperfusion. MOL THER 30:1275–1287. https://doi.org/10.1016/j.ymthe.2021.11.004 - DOI - PubMed - PMC
MeSH terms
LinkOut - more resources
Full Text Sources